These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9501773)

  • 1. Anti-D immunoglobulin in RhD prophylaxis.
    Robson SC; Lee D; Urbaniak S
    Br J Obstet Gynaecol; 1998 Feb; 105(2):129-34. PubMed ID: 9501773
    [No Abstract]   [Full Text] [Related]  

  • 2. Economics of antenatal prophylaxis.
    Cairns JA
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():19-22. PubMed ID: 9863974
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for antenatal anti-D prophylaxis.
    Mason G; Glanville T
    Lancet; 2002 Sep; 360(9336):880. PubMed ID: 12243957
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing Rh immunisation.
    Letsky EA; de Silva M
    BMJ; 1994 Jul; 309(6949):213-4. PubMed ID: 7848416
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of anti-D immunoglobulin in maternal trauma.
    Eager R; Sutton J; Spedding R; Wallis R
    Emerg Med J; 2003 Sep; 20(5):498. PubMed ID: 12954709
    [No Abstract]   [Full Text] [Related]  

  • 7. High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis.
    Saramago P; Yang H; Llewellyn A; Palmer S; Simmonds M; Griffin S
    BJOG; 2018 Oct; 125(11):1414-1422. PubMed ID: 29415334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D administration after childbirth for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 May; 2(5):10-1. PubMed ID: 12024602
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.
    Int J Gynaecol Obstet; 1999 Jul; 66(1):63-70. PubMed ID: 10458556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antenatal anti-Rh(D) antigen prophylaxis].
    Katsulov A;
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
    [No Abstract]   [Full Text] [Related]  

  • 13. The scientific basis of antenatal prophylaxis.
    Urbaniak SJ
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme.
    Mayne S; Parker JH; Harden TA; Dodds SD; Beale JA
    BMJ; 1997 Dec; 315(7122):1588. PubMed ID: 9437277
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
    Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
    [No Abstract]   [Full Text] [Related]  

  • 16. Costs and benefits of non-invasive fetal RhD determination.
    Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhD isoimmunization and current management modalities.
    Neal JL
    J Obstet Gynecol Neonatal Nurs; 2001; 30(6):589-606. PubMed ID: 11724195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department.
    Weinberg L
    Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should the RhD prophylaxis be adjusted?].
    Georgsen J; Sprogøe U
    Ugeskr Laeger; 2004 Aug; 166(36):3072. PubMed ID: 15446237
    [No Abstract]   [Full Text] [Related]  

  • 20. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
    Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
    Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.